ATM and breast carcinoma: Thompson et al. conducted a prospective study involving 247 heterozygous carriers of ATM mutations and found a higher relative risk for developing breast cancer in carriers <50 years of age (RR = 4.94; 95%CI: 1.9–12.9) compared to the general population [148].